Anxiety disorder

Brain and Nerve

Volumn 64, Issue 2, 2012, Pages 131-138

  Inoue, Takeshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amygdala; Anxiety disorder; Neuroimaging; Selective serotonin reuptake inhibitors (SSRI); Serotonin

Indexed keywords

CHOLINESTERASE REACTIVATOR; CYCLOSERINE; NEUROTRANSMITTER; PROPANOL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANXIETY; ANXIETY DISORDER; DRUG EFFECT; DRUG EFFICACY; FEAR; HUMAN; NERVE CELL; NEUROIMAGING; NONHUMAN; REVIEW; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; DISEASE MODELS, ANIMAL; FEAR; HUMANS;

EID: 84857289199     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Zohar J, Westenberg HG: Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403: 39-49, 2000
2. Merikangas KR, Pine D: Genetic and other vulnerability factors for anxiety and stress disorders. Neuropsychopharmacology: The Fifth Generation of Progress (Davis KL, Charney D, Coyle JT, Nemeroff C, eds). Philadelphia: Lippincott Williams & Wilkins; 2002: 867-882
3. Charney DS, Drevets WC: Neurobiological basis of anxiety disorders. Neuropsychopharmacology: The Fifth Generation of Progress (Davis KL, Charney D, Coyle JT, Nemeroff C, eds). Philadelphia: Lippincott Williams & Wilkins; 2002: 901-930
4. Rauch SL, Shin LM: Structural and functional imaging of anxiety and stress disorders. Neuropsychopharmacology: The Fifth Generation of Progress (Davis KL, Charney D, Coyle JT, Nemeroff C, eds). Philadelphia: Lippincott Williams & Wilkins; 2002: 953-966
5. Anagnostaras SG, Gale GD, Fanselow MS: Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11: 8-17, 2001
6. Nader K, Schafe GE, Le Doux JE: Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406: 722-726, 2000
7. LeDoux JE. The amygdala and emotion: a view through fear. The amygdala: a functional analysis, 2nd ed. (Aggleton J, ed). Oxford: Oxford University Press; 2000: 289-310
8. Sotres-Bayon F, Cain CK, LeDoux JE: Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry 60: 329-336, 2006 (Pubitemid 44215846)
9. Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, et al: Amygdala inhibitory circuits and the control of fear memory. Neuron 62: 757-771, 2009
10. Gorman JM, Liebowitz MR, Fyer AJ, Stein J: A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 146: 148-161, 1989 (Pubitemid 19059560)
11. Gorman JM, Kent JM, Sullivan GM, Coplan JD: Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157: 493-505, 2000 (Pubitemid 30191187)
12. Shin LM, Liberzon I: The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35: 169-191, 2010
13. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, et al: Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59: 425-433, 2002 (Pubitemid 34477677)
14. Smoller JW, Block SR, Young MM: Genetics of anxiety disorders: the complex road from DSM to DNA. Depress Anxiety 26: 965-975, 2009
15. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, et al: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389, 2003 (Pubitemid 36877077)
16. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, et al: Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299: 1291-1305, 2008 (Pubitemid 351439075)
17. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, et al: Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 66: 1201-1209, 2009
18. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, et al: Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35: 1684-1692, 2010
19. Inoue T, Kitaichi Y, Koyama T: SSRIs and conditioned fear. Prog Neuropsychopharmacol Biol Psychiatry 35: 1810-1819, 2011
20. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, et al: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 9: 248-312, 2008
21. Norberg MM, Krystal JH, Tolin DF: A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 63: 1118-1126, 2008
22. Mueller D, Cahill SP: Noradrenergic modulation of extinction learning and exposure therapy. Behav Brain Res 208: 1-11, 2010
23. Monfils MH, Cowansage KK, Klann E, LeDoux JE: Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 324: 951-955, 2009
24. Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, et al: Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463: 49-53, 2010
25. Inoue T, Hashimoto S, Izumi T, Maki Y, Muraki I, et al: Serotonergic neurotransmission and defensive freezing in the conditioned fear stress paradigm. Affective minds (Hatano G, Okada N, Tanabe H, eds). Amsterdam, Elsevier Science, 2000, pp91-100